Research Groups and R&D Platforms: Antibodies

Research Group:
Cardiac Biomarkers

Saara Wittfooth
saara.wittfooth@utu.fi

Department of Life Technologies,
University of Turku

Saara Wittfooth

Ageing-related diseases, Antibodies, Assay development, Autoimmune diseases, Biomarker, Biotechnology, Cardiovascular diseases, Clinical Chemistry, Clinical Medicine, In Vitro Diagnostics, Inflammation, Metabolic diseases, Obesity

Research Group:
Lyme borreliosis: A comprehensive approach

Jukka Hytönen
jukka.hytonen[at]utu.fi

Institute of Biomedicine,
University of Turku

Jukka Hytönen

Antibodies, Assay development, Bacteriology, Biomarker, Biomedicine, Clinical Medicine, Disease models, Epidemiology, Genomics, Imaging, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Infection, Inflammation, Molecular Biology, Molecular Cell Biology, Molecular diagnostics, PET, Point of care, X-ray crystallography

Research Group:
Drug Discovery and Diagnostics tools and detection methods

Harri Härmä
harri.harma[at]utu.fi

Analytical Chemistry,
University of Turku

Harri Härmä

Antibodies, Assay development, Biomarker, Biomedicine, Biomolecular chemistry, Biotechnology, Clinical Chemistry, Diagnostics, Drug target, Fluorescence spectroscopy, FTIR or RAMAN microscopy, FTIR or RAMAN spectroscopy, In Vitro Diagnostics, Molecular diagnostics, Nanoparticles, Next-generation sequencing, Nucleic acids, Particle size analysis, Pattern recognition, Personalized medicine, Receptor, Screening, Signaling, Thermal analysis

Research Group:
Bacterial infections: translational genomics, immunity and prevention

Qiushui He
Qiushui.He[at]utu.fi

Institute of Biomedicine,
University of Turku

Qiushui He

Allergy, Antibodies, Assay development, Bacteriology, Biomedicine, Epidemiology, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Infection, Inflammation, Molecular diagnostics, Nucleic acids

Research Group:
New tools to target harmful inflammations and cancer

Sirpa Jalkanen
sirjal[at]utu.fi

Institute of Biomedicine,
University of Turku

Sirpa Jalkanen

Cell Trafficking in Cancer and Inflammation

Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Biopharmaceuticals, Breast cancer, Cancer, Cardiovascular diseases, Clinical Medicine, Colorectal cancer, Diagnostics, Disease models, Drug target, Imaging, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Lung cancer, Melanoma, Metabolic diseases, Molecular Cell Biology, Molecular diagnostics, Musculoskeletal disorders, Neurological disorders, Obesity, Ovarian cancer, Pathology, Personalized medicine, PET, Prostate cancer, Receptor, Signaling, Skin diseases, Squamous cell carcinoma, Target discovery

Research Group:
B lymphocyte activation and the role of the cytoskeleton in health and disease

Pieta Mattila
pieta.mattila[at]utu.fi

Institute of Biomedicine,
University of Turku

Pieta Mattila

Mattila Lab

Allergy, Antibodies, Autoimmune diseases, Basic research, Biomedicine, Cancer, Drug target, Imaging, Immunology, Infection, Inflammation, Inherited diseases, Molecular Cell Biology, Pathology, Proteomics, Receptor, Signaling, Super-resolution imaging, Target discovery